Semaglutide, the active ingredient in Ozempic and Wegovy, was associated with fewer psychiatric hospital admissions among people with bipolar disorder in a large Swedish study. The finding raises the possibility that a medicine used for diabetes and weight management could have effects beyond metabolism. Bipolar disorder involves episodes of depression and elevated mood that can […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.